Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures, and commercializes specialized products that find application in life science research. The major customers of the company include research scientists at pharmaceutical and biotechnology firms, academic institutions, contract research organizations, government laboratories and hospitals. The company operates through single segment which involves the design, development, production and distribution of products and services.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Harvard Bioscience’s research and development (R&D) activities focus on the development of products that provide potential growth opportunities in life science research. It also conducts research activities to design and develop new products and to maintain and optimize its existing product portfolios. The company aims to develop new products through internal research and acquire products through business and technology acquisitions. In FY2024, the company spent US$10.4 million on its R&D activities, which as a percentage of revenue stood at 11.1%.